Hyperkalemia is a serious, often life threatening complication of diabetes-related kidney disease. This is one of the most common electrolyte imbalances experienced by people with kidney disease, or ...

Diabetic nephropathy is a complication of diabetes that affects the kidneys. Hyperkalemia refers to high levels of potassium in the blood. Damage to the kidneys can result in hyperkalemia. Diabetic ...

When you have too much potassium in your blood, it’s called hyperkalemia. There are two types of hyperkalemia: acute and chronic. Acute hyperkalemia is a sudden, severe rise in blood potassium levels.

Hyperkalemia is common among elderly patients and is associated with an increase in morbidity and mortality. Patients at highest risk for developing hyperkalemia are those with chronic kidney disease ...

Angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers are used commonly in clinical practice to treat hypertension and decrease cardiovascular events in high-risk patients.

July 7, 2010 — Use of trimethoprim-sulfamethoxazole (TMP-SMX) may increase risk for hyperkalemia requiring hospitalization in older adults, but there is no added risk when used in combination with ...

Hyperkalemia refers to high potassium levels in the blood. Symptoms are rare in the first phases, but they may include weakness, fatigue, and heart arrhythmias. Prompt medical care is essential. High ...

If you have hyperkalemia, you have high levels of potassium in your blood. If you don’t get your potassium under control, the condition can be life-threatening. That’s why it’s important to advocate ...

Hyperkalemia is a potentially serious condition that can result in life-threatening cardiac arrhythmias and is associated with an increased mortality risk. Patients older than 65 years who have an ...

Searching for effective treatment options for 'Hyperkalemia symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

The Randomized Aldactone Evaluation Study (RALES) demonstrated that spironolactone significantly improves outcomes in patients with severe heart failure. Use of angiotensin-converting–enzyme (ACE) ...